Vancouver, British Columbia — January 5, 2026 — Leads & Copy — Telescope Innovations Corp. is seeing accelerating commercial adoption of Self-Driving Labs (SDLs) and the global expansion of Physical AI. This follows the Company’s recent successful deployment of a pharmaceutical SDL for the Korea Pharmaceutical and Biopharmaceutical Manufacturers Association (KPBMA), which serves as a blueprint for sectors seeking to drastically accelerate the R&D of advanced materials through automated, data-rich experimentation.
According to the company, a Self-Driving Lab is a fixed-position physical AI platform that integrates robotics, inline analytics, and machine learning to run experiments in a continuous, autonomous closed-loop workflow. Telescope says the SDL is not a vehicle or a mobile lab, but a sophisticated industrial asset. The “self-driving” nomenclature refers to the platform’s ability to navigate toward a research goal, rather than physical roads. By autonomously hypothesizing, testing, and refining results without human intervention, SDLs eliminate common manual errors in dosing and data reporting while operating safely in hazardous or remote environments.
Telescope Innovations Corp. is seeing commercial momentum that aligns with recent industry intelligence from leading research firms. Gartner (October 20, 2025) has identified Physical AI as a top strategic technology trend for 2026, representing the embodiment of intelligence within autonomous robotic systems. Gartner also predicts that by 2028, over 50% of enterprise AI models will be domain-specific, trained on niche, specialized datasets rather than general-purpose information. According to Telescope, its strategic SDL focus provides the engine for this shift, generating the high-quality “ground truth” chemical data required to fuel these models.
Research from Global X (May 14, 2025) suggests the economy has entered an “Automation Age.” Global X notes that the fusion of digital intelligence with physical hardware could trigger a new industrial super-cycle, accelerating growth across previously siloed sectors. In its December 2025 report, Grand View Research projected the global lab-automation market will reach approximately US $18.39 billion by 2033, growing at a CAGR of 9.3%.
According to Henry Dubina, CEO of Telescope Innovations, Telescope is positioned at the intersection of chemical engineering and Physical AI. Dubina stated that the company’s funded SDL programs with global pharmaceutical leaders to its record sales performance this past year, FY 2025 marked an important transition from development to commercialization. Dubina also stated that its successful installation in Korea proves that their SDL architecture is a ready-to-deploy industrial asset that delivers the high-quality, domain-specific data now required by the world’s leading organizations to maintain their competitive edge.
Telescope’s SDL architecture is designed for scalability across multiple high-stakes verticals, including pharmaceuticals; industrial chemistry; agriculture & energy; and space & off-earth research, where autonomous labs can perform microgravity research or life-support chemistry where human presence is impractical.
Telescope Innovations Corp. builds and deploys enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality across the health and sustainability sectors.
Henry Dubina, Chief Executive Officer
E: henry.dubina@telescopeinn.com
Source: Telescope Innovations Corp.
